Givlaari Disease Interactions
There is 1 disease interaction with Givlaari (givosiran).
Givosiran (applies to Givlaari) hepatic/renal
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction, Liver Disease
The effect of end-stage renal disease (eGFR <15 mL/min/1.73m2), and moderate to severe hepatic impairment on givosiran pharmacokinetics is unknown. Additionally, hepatic and renal toxicity was observed in up to 15% of patients treated with givosiran in clinical trials. Caution and regular monitoring is advised when using givosiran in patients with hepatic or renal impairment.
Switch to professional interaction data
Givlaari drug interactions
There are 239 drug interactions with Givlaari (givosiran).
Givlaari alcohol/food interactions
There is 1 alcohol/food interaction with Givlaari (givosiran).
Report options
More about Givlaari (givosiran)
- Givlaari consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Thorazine
Thorazine is used for hiccups, light sedation, mania, nausea/vomiting, opiate withdrawal ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Afamelanotide
Afamelanotide is used for prevention of phototoxicity in erythropoietic protoporphyria
Chlorpromazine
Chlorpromazine is used for hiccups, light sedation, mania, nausea/vomiting, opiate withdrawal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
